ArticleJournal for immunotherapy of cancer2021

Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer.

Jacob Gadwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.